AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation
Faster Insights or Faster Fail? How to Avoid the Misuse of Real-World Data when Using AI
Using Real-World Data to Understand the Impact of IRA Policy on Patient Outcomes and Health Equity
From weeks to minutes: How generative AI transforms pharma data and ROI
Maximize Real World Data Value with Panalgo on AWS
Data advancements are finally unlocking drug safety during pregnancy
The ABCs of SDOH: Meaningful strategies to improve patient outcomes
How AI and ML are Reshaping the Research Landscape
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support decision making from R&D through to market access – share their worries and hopes going into 2024. Read the Full Article
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect Studies (CNODES) and Professor at McGill University, discuss how the use of real-world evidence can prevent pharma companies from performing studies based on flawed data. Read the Full Article